Abstract
Goreisan might be a medicine to cure the pain caused by thirst and dry mouth symptom of glossodynia. All registered patients were treated with Goreisan by taking 7.5 g / day (min 3) for 2 weeks. Self-filled Visual Analogue Scale (VAS) and tongue perception test by nomo-filament. Furthermore, daily self-filled VAS evaluation was required patients’ home for two weeks during Goreisan administration. There was 57% of patients (8/14) showed “improved” after administration of 2 weeks Goreisan administration based on the criteria of 20% reduction of VAS compared to baseline. Self-filled VAS score was significant low (p = 0.006) at 2 weeks evaluation at second visit and remained lower level through 4 week observation periods compared to baseline value. QST significantly increased after 2 weeks administration of Goreisan (p = 0.008) and remained higher level through 4 week observation periods compared to baseline value. There was significant reduction of daily self-filled VAS patients’ home at day 3 and day 13 ~ day 14. (p < 0.05). There is a weak positive and negative correlation between Barometric pressure (hPa) and self-filled VAS scale (cm) in each patients. The administration of Goreisan for two weeks lead to significant reduction of pain perception based on the evaluation of Self-filled pain scale (VAS) and tongue perception test (QST). There is correlation between barometric pressure and self-filled VAS scale. This fact might indicate that Goreisan would be the alternative treatment for glossodynia patients. Goreisan would be a successful alternative treatment modality for glossodynia patients.
Trial registration Current Controlled trials was registered with the UMIN Clinical Trials Registry (identifier: UMIN000035965, 02.21.2019).
Similar content being viewed by others
Abbreviations
- VAS:
-
Visual analogue scale
- QST:
-
Tongue quantitative sensory test
References
Bessho K, Okubo Y, Hori S, Murakami K, Iizuka T (1998) Effectiveness of kampo medicine (sai-boku-to) in treatment of patients with glossodynia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86(6):682–686
Hijikata Y, Makiura N, Kano T, Higasa K, Shimizu M, Kawata K, Mine T (2008) Kampo medicine, based on traditional medicine theory, in treating uncured glossodynia: efficacy in five clinical cases. Am J Chin Med 36(5):835–847. https://doi.org/10.1142/S0192415X08006284
Okamoto H (2013) A valid approach in refractory Glossodynia; a singl-institute 5-year experience treating with Japanese traditional herbal (Kampo) medicine. Evid-Based Complement Altern Med 2013:1–8
Sato J (2015) Weather changes and pain. Spinal Surg 29(2):153–156
Sato J (2016) Mechanisms of worsening chronic pain due to changes in the weather environment. J Clin Anesth 40(10):1367–1373
Sato S (2018) A case of elderly patient whose dry mouth and chronic depression improved with Gosansan. Clin Psychiatr 60(5):153–156
Sato J, Aoyama M, Yamazaki M, Okumura S, Takahashi K, Funakubo M, Mizumura K (2004) Artificially produced meteorological changes aggravate pain in adjuvant-induced arthritic rats. Neurosci Lett 354(1):46–49. https://doi.org/10.1016/j.neulet.2003.09.057
Sato J, Inagaki H, Kusui M, Yokosuka M, Ushida T (2019) Lowering barometric pressure induces neuronal activation in the superior vestibular nucleus in mice. PLoS One 14(1):e0211297. https://doi.org/10.1371/journal.pone.0211297
Sato J, Morimae H, Seino Y, Kobayashi T, Suzuki N, Mizumura K (1999) Lowering barometric pressure aggravates mechanical allodynia and hyperalgesia in a rat model of neuropathic pain. Neurosci Lett 266(1):21–24. https://doi.org/10.1016/s0304-3940(99)00260-8
Sato J, Morimae H, Takanari K, Seino Y, Okada T, Suzuki M, Mizumura K (2000) Effects of lowering ambient temperature on pain-related behaviors in a rat model of neuropathic pain. Exp Brain Res 133(4):442–449. https://doi.org/10.1007/s002210000451
Sugiyama T (2018) Kampo treatment for dry mouth. Nihon shααika toyo igakkaishi 37(1–2):12–18
Toyoda Y, Somekawa S, Narumi F, Okawa Y, Ueda S, Matsumoto D, Ohkawa S (2018) Usefulness of herbal treatment for dry mouth. J Jpn Acad Occlusion Health 24(1):1–5
Acknowledgements
We would like to express our deepest gratitude to Sawako Nakashima and Naoki Hosogaya. This work was supported by the institutional budget in Nagasaki University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
The study was approved by the institutional review board of Nagasaki University, Nagasaki, Japan. Patients provided written informed consent after receiving a complete description of the study. This trial was registered with the University hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR) (identifier: UMIN000035965).
Conflict of interest
Ichiro Okayasu has no conflict of interest. Tachi Mizuki has no conflict of interest. Takuro Sanuki has no conflict of interest. Shinji Kurata has no conflict of interest. Takao Ayuse has no conflict of interest.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Okayasu, I., Mizuki, T., Sanuki, T. et al. A pilot study of pain-relieving effect of Goreisan in glossodynia with dry mouth symptoms: an open-label single-group study. ADV TRADIT MED (ADTM) 21, 323–329 (2021). https://doi.org/10.1007/s13596-020-00441-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-020-00441-x